The Laboratory of Bacteriology (LB) studies bacteria that cause important human infections, including Chlamydia, Coxiella, Francisella, Rickettsia, and Salmonella. In addition, LB conducts research with pathogens listed as serious or urgent threats in the National Action Plan for Combating Antibiotic-Resistant Bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Klebsiella pneumoniae. The ultimate goal of our research is to identify novel or improved strategies to control bacterial diseases, including development of diagnostics, vaccines, and therapeutics. LB maintains a flexible laboratory and theoretical infrastructure to permit analysis of bacterial pathogens of special interest.
See the National Action Plan for Combating Antiobiotic-Resistant Bacteria (PDF).
Frank R. DeLeo, Ph.D.
Michael Otto, Ph.D.
Robert A. Heinzen, Ph.D.
David W. (Ted) Hackstadt, Ph.D.
Catharine (Katy) Bosio, Ph.D.
Olivia Steele-Mortimer, Ph.D.
Last Updated June 30, 2015